NLRP3 and metabolic dysfunction-associated steatohepatitis: This study provides the experimental evidence that Pr2x7 gene deletion results in attenuation of NASH induced by a HFD, a well-established model of the human metabolic syndrome, as well as in blunted expression and activation of the NLRP3 inflammasome, which may ultimately mediate protection from liver injury.